Policy
Section
Pol.
Tracking legislation, regulation, and the fight for federal reform.
Section Editor
Ethan Vale — The Strategist
Federal Bills — 2026 Session
Updated Apr 22
View All Bills →
| Bill # | Name | Status | Chamber | Last Action |
|---|---|---|---|---|
|
S.1234
Senate
|
Secure and Fair Enforcement Regulation Banking Act of 2026
Senate Banking Committee advanced bill 12-10 along party lines; floor vote expected Q2 2026
|
In Committee | Federal | Mar 18, 2026 |
|
DEA-2026-01
Executive
|
DEA Final Rule: Cannabis Reclassification from Schedule I to Schedule III
AG Pam Bondi fired April 3; Todd Blanche named interim AG. Early analysis indicates rescheduling trajectory unchanged — Trump has directed DOJ to complete Schedule III rulemaking expeditiously. DEA final rule still expected late 2026.
|
Pending | Federal | Apr 3, 2026 |
|
H.R. 2072
House
|
Veterans Equal Access to Cannabis Therapy Act of 2026
Referred to House Veterans' Affairs Committee; bipartisan co-sponsors added
|
Introduced | Federal | Feb 14, 2026 |
|
S.2089
Senate
|
States Reform Act of 2026
Introduced; referred to Senate Judiciary Committee
|
Introduced | Federal | Jan 28, 2026 |
|
H.R. 4089
House
|
Marijuana Opportunity Commerce and Accountability Act of 2026
House Judiciary subcommittee hearing held; markup scheduled for April
|
In Committee | Federal | Mar 5, 2026 |
|
CMS-BEI-2026
Executive/CMS
|
CMS Substance Access Beneficiary Engagement Incentive — Hemp Products
D.C. federal court denied emergency restraining order; injunction hearing set for April 20, 2026. Program launched April 1 for ACO REACH and EOM model participants.
|
Active_litigation | Federal | Apr 2, 2026 |
|
S.1876
Senate
|
Cannabidiol and Marihuana Research Expansion Act Reauthorization 2026
Passed Senate 92-4; awaiting House floor vote
|
Passed | Federal | Feb 22, 2026 |
|
H.R. 8394
House
|
To streamline the process for institutions of higher education to research marijuana.
Referred to Committees on Energy and Commerce, Judiciary, Agriculture, and Education and Workforce
|
Introduced | Federal | Apr 20, 2026 |
Federal Reform
All Federal →
Policy
The DEA’s June 26 Cannabis Registration Deadline Is 16 Days Away. Fewer Than 500 Businesses Have Signed Up.
Jordan Pike
·
Jun 10
Policy
Legal But Unreachable: The UK’s Medical Cannabis Access Crisis Is a Warning for What Comes After Rescheduling
Ethan Vale
·
Jun 1
Policy
Three Republican State AGs Just Sued Trump’s DOJ to Stop Cannabis Rescheduling. Here’s Why That’s a Bigger Deal Than It Sounds.
Jordan Pike
·
Jun 1
State Legislation
All States →
Policy
Democratic Lawmakers Are Asking Trump to Commute Every Federal Marijuana Sentence. Here’s What That Would Actually Take.
Ethan Vale
·
May 29
Policy
After 280E: Why Smart Cannabis Operators Are Turning Their Tax Savings Into Financial Assets
Ethan Vale
·
May 27
Policy
Louisiana Just Passed One of the Harshest School-Zone Marijuana Laws in the South. Critics Say It’s a Map Problem.
Jordan Pike
·
May 27
Regulation & Compliance
All Regulation →
Policy
New Research Links Cannabis to Sustained Opioid Reductions and Arthritis Relief — the Policy Still Hasn’t Caught Up
Ethan Vale
·
May 25
Policy
Splitsville: How Schedule III Is Creating Two Separate Cannabis Industries
Ethan Vale
·
May 15
Policy
Indiana Residents Spend $2 Billion a Year on Cannabis — And the State Spends $20 Million to Stop Them
Jordan Pike
·
May 11
International Policy
Global Coverage →
Policy
The Trump Administration’s Drug Strategy Is Out. Marijuana Gets Its Own Chapter.
Ethan Vale
·
May 11
Policy
The Feds Are Closing In on Intoxicating Hemp — and the DEA Just Made the Legal Case
Ethan Vale
·
May 8
Policy
Trump’s Rescheduling Order Is Real — and It’s Already Creating More Confusion Than Clarity
Ethan Vale
·
May 5
◆ Data Feature · Rescheduling Watch
Federal Rescheduling Is No Longer a Question of If — It’s a Question of What Comes Next
The DEA’s administrative law hearing marks the first time federal cannabis policy will be argued in open court with formal evidentiary standards. A Schedule III ruling won’t end the fight — it will redefine it. Banking restrictions, 280E taxation, and interstate commerce remain locked until Congress acts. Here’s the full policy landscape heading into the hearing.
Sched. III
Proposed Status
47 days
To DEA Hearing
24 states
Rec. Legal
68 %
Congressional Support
Schedule Status
I → III
Proposed reclassification pending hearing
DEA Hearing Timeline
May 2026
Administrative Law Court, Washington D.C.
States Legalized
24 rec.
38 medical · as of March 2026
Congressional Support
68%
Bipartisan majority across House & Senate
Analysis & Voices
Analysis
The DEA’s June 26 Cannabis Registration Deadline Is 16 Days Away. Fewer Than 500 Businesses Have Signed Up.
The DEA opened its Schedule III cannabis registration portal in April. As of early June, fewer than 500 businesses had enrolled — a fraction of the tens of thousands of licensed operators across 38 medical states. With 16 days left, here's what the data shows.
Read the full analysis →
June 10, 2026
Analysis
Legal But Unreachable: The UK’s Medical Cannabis Access Crisis Is a Warning for What Comes After Rescheduling
The United Kingdom legalized medical cannabis in 2018 — yet most patients still can't access it through the public health system, forced instead into a costly private market. As the United States edges toward its own rescheduling milestone, the UK's eight-year access failure offers an uncomfortable preview.
Read the full analysis →
June 1, 2026